Ribociclib in India is known by the brand name Kryxana. The brand ownership and commercial rights of Ribociclib are with Novartis. It is a global Multinational company with established presence in India. Ribociclib is stocked by its licensed dealers and authorized distributors. Kryxana Novartis Price is restricted by MRP. Cancer speciality Pharmacies can order this medicine for their patients. There are special outlets that promote and facilitate Cancer Medicines in India. Companies similar to Novartis arrive at special prices and patient support programs to make lifesaving drugs affordable. They have the liberty to make that discretion.
Kryxana Price in India is more or less the same in all Indian cities. The pricing strategy is adopted based on the company’s assessment and the same is uniformly followed by the authorized dealers. It may probably be noted that Ribociclib in India has a different trade name or identity. The brand name is different in various other international markets. Technical reasons are often cited for such a differentiation. There is also some considerable cost difference which directly benefits Indian patients. These drugs are mostly covered by the insurance companies. Patients with institutional coverage can further benefit. Medical Oncologists prescribe this medication.
Kryxana 200mg packs can be accessed and purchased from the speciality dealers and distributors. If you require more assistance regarding the cost and other related factors of this drug, you can consider professional help. We will assist you to validate cost and proactively share relevant market information. When you contact us, we will let you know if any ongoing special prices are available. You may explore more possibilities.